Walter J. Koroshetz, M.D., FAAN

Dr. Koroshetz served as Director of the National Institute of Neurological Disorders and Stroke ‘15-,26. He joined NINDS in ‘07 as Deputy Director and has held leadership roles in a number of trans-NIH and NINDS programs including: co-leading the NIH’s BRAIN Initiative, the NIH RECOVER Initiative on Post Acute Sequelae of COVID-19, NIH Blueprint for Neuroscience, the TBI Center between the NIH and the Uniformed Health Services University, the Helping to End Addiction Long Term) Initiative as well as Accelerated Medicine Partnerships in Parkinson’s and ALS. He co-led a number of NIH Common Fund’s programs including the Undiagnosed Disease Network, the Acute to Chronic Pain Transition programs, Somatic Gene Editing program and Somatic Mosaicism in Human Tissue. He founded the BRAIN Initiative NeuroEthics Working Group and was an active member. In 2020 he received the International Neuroethics Society’s 2020 Steven Hyman Award for Distinguished Service.

Before joining NINDS, Dr. Koroshetz served as Vice Chair of the neurology service and Director of stroke and neurointensive care services at Massachusetts General Hospital (MGH). He was a professor of Neurology at Harvard Medical School (HMS) and led neurology resident training at MGH between 1990 and 2007. His early research in the lab and clinic focused on Huntington’s disease and with the team at MGH performed the first study of pre-symptomatic testing.